53 filings
8-K
NGM
Ngm Biopharmaceuticals Inc
5 Apr 24
NGM Bio Announces Closing of Tender Offer
10:10am
8-K
NGM
Ngm Biopharmaceuticals Inc
11 Mar 24
NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results
4:13pm
8-K
NGM
Ngm Biopharmaceuticals Inc
26 Feb 24
NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP
5:01pm
8-K
NGM
Ngm Biopharmaceuticals Inc
22 Jan 24
Other Events
6:09am
8-K
NGM
Ngm Biopharmaceuticals Inc
2 Jan 24
Other Events
7:30am
8-K
qvcc39lj83j121gsrxb
4 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:19pm
8-K
6nf4r4nj
2 Nov 23
NGM Bio Reports Third Quarter 2023 Financial Results and Provides Business Highlights
4:06pm
8-K
sv9f5
17 Oct 23
Departure of Directors or Certain Officers
5:28pm
8-K/A
ja6b5imfjomvt6uja2
11 Sep 23
Departure of Directors or Certain Officers
4:01pm
8-K
27fjj cilumav2hs
11 Aug 23
Departure of Directors or Certain Officers
4:08pm
8-K
hjnn9296 c16ea
3 Aug 23
NGM Bio Reports Second Quarter 2023 Financial Results and Provides Business Highlights
4:07pm
8-K
g46wf3
8 Jun 23
Other Events
6:06am
8-K
hyfsbdgp5 gx14f7j
12 May 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
sj6yfpw7
4 May 23
NGM Bio Reports First Quarter 2023 Financial Results and Provides Business Highlights, Including Topline ALPINE 4 Data
4:11pm
8-K
vjcligjdmmyplcv
4 Apr 23
Cost Associated with Exit or Disposal Activities
4:06pm
8-K
zpgkhtb hz37j2uthoj4
28 Feb 23
NGM Bio Provides Business Highlights and Reports Fourth Quarter and Full Year 2022 Financial Results
4:13pm
8-K
ao50v9 6192erg5663uh
20 Dec 22
Other Events
4:06pm
8-K
ackvc3
3 Nov 22
NGM Bio Provides Business Highlights and Reports Third Quarter 2022 Financial Results
4:12pm
8-K
mccn8
17 Oct 22
Results of Operations and Financial Condition
7:40am
8-K
sfdc82m
4 Aug 22
NGM Bio Provides Business Highlights and Reports Second Quarter 2022 Financial Results
4:13pm